Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Engineered T Cells industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Redmile Group
Oxford Biomedica
Autolus Limited
Cells Medica
Pfizer
Bellicum Pharmaceuticals
Precision Bioscience
Unum Therapeutics
Novartis
Juno Therapeutics
Gilead Sciences
By Type:
Chimeric Antigen Receptor (CAR)
T Cell Receptor {TCR}
Tumor Infiltrating Lymphocytes
By Application:
Cancer Research Centers
Clinics
Hospitals
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Engineered T Cells Market Overview 2018-2029
-
1.1 China Engineered T Cells Industry Development Overview
-
1.2 China Engineered T Cells Industry Development History
-
1.3 China Engineered T Cells Industry Market Size (2018-2029)
-
1.4 China Engineered T Cells Market Analysis by Type from Production Side
-
1.4.1 China Engineered T Cells Production Volume, Production Value and Growth Rate of Chimeric Antigen Receptor (CAR) (2018-2029)
-
1.4.2 China Engineered T Cells Production Volume, Production Value and Growth Rate of T Cell Receptor {TCR} (2018-2029)
-
1.4.3 China Engineered T Cells Production Volume, Production Value and Growth Rate of Tumor Infiltrating Lymphocytes (2018-2029)
-
1.5 China Engineered T Cells Market Analysis by Application from Consumption End
-
1.5.1 China Engineered T Cells Sales Volume, Sales Value and Growth Rate of Cancer Research Centers (2018-2029)
-
1.5.2 China Engineered T Cells Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)
-
1.5.3 China Engineered T Cells Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.6 China Engineered T Cells Market Analysis by Region
-
1.6.1 North China Engineered T Cells Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Engineered T Cells Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Engineered T Cells Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Engineered T Cells Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Engineered T Cells Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Engineered T Cells Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Engineered T Cells Market Size and Growth Rate from 2018-2029
Chapter 2 China Engineered T Cells Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Engineered T Cells Market Status and Competition at home and abroad in 2023
-
2.2.2 China Engineered T Cells Market Status and Competition Analysis in 2023
-
2.2.3 China Engineered T Cells Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Engineered T Cells Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Engineered T Cells Industry Development
Chapter 3 Engineered T CellsIndustry Chain Analysis
-
3.1 Engineered T Cells Industry Chain
-
3.2 Engineered T Cells Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Engineered T Cells Market
-
3.3 Engineered T Cells Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Engineered T Cells Market
Chapter 4 China Engineered T Cells Market, by Type
-
4.1 China Engineered T Cells Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Engineered T Cells Total Production Volume and Growth Rate from Production Side
-
4.5 China Engineered T Cells Production Volume and Growth Rate, by Type
-
4.5.1 China Engineered T Cells Production Volume and Growth Rate of Chimeric Antigen Receptor (CAR)
-
4.5.2 China Engineered T Cells Production Volume and Growth Rate of T Cell Receptor {TCR}
-
4.5.3 China Engineered T Cells Production Volume and Growth Rate of Tumor Infiltrating Lymphocytes
Chapter 5 China Engineered T Cells Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Engineered T Cells Total Market Size and Growth Rate from Consumption End
-
5.5 China Engineered T Cells Market Size and Growth Rate, by Application
-
5.5.1 China Engineered T Cells Market Size and Growth Rate of Cancer Research Centers
-
5.5.2 China Engineered T Cells Market Size and Growth Rate of Clinics
-
5.5.3 China Engineered T Cells Market Size and Growth Rate of Hospitals
Chapter 6 China Engineered T Cells Market, by Region
-
6.1 China Engineered T Cells Production Volume and Production Value, by Region
-
6.2 China Engineered T Cells Sales Volume and Sales Value, by Region
Chapter 7 North China Engineered T Cells Market Analysis
-
7.1 North China Engineered T Cells Market, by Type
-
7.2 North China Engineered T Cells Market, by Application
Chapter 8 Central China Engineered T Cells Market Analysis
-
8.1 Central China Engineered T Cells Market, by Type
-
8.2 Central China Engineered T Cells Market, by Application
Chapter 9 South China Engineered T Cells Market Analysis
-
9.1 South China Engineered T Cells Market, by Type
-
9.2 South China Engineered T Cells Market, by Application
Chapter 10 East China Engineered T Cells Market Analysis
-
10.1 East China Engineered T Cells Market, by Type
-
10.2 East China Engineered T Cells Market, by Application
Chapter 11 Northeast China Engineered T Cells Market Analysis
-
11.1 Northeast China Engineered T Cells Market, by Type
-
11.2 Northeast China Engineered T Cells Market, by Application
Chapter 12 Southwest China Engineered T Cells Market Analysis
-
12.1 Southwest China Engineered T Cells Market, by Type
-
12.2 Southwest China Engineered T Cells Market, by Application
Chapter 13 Northwest China Engineered T Cells Market Analysis
-
13.1 Northwest China Engineered T Cells Market, by Type
-
13.2 Northwest China Engineered T Cells Market, by Application
Chapter 14 Company Profiles
-
14.1 Redmile Group
-
14.1.1 Redmile Group Company Profile
-
14.1.2 Redmile Group Engineered T Cells Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Oxford Biomedica
-
14.2.1 Oxford Biomedica Company Profile
-
14.2.2 Oxford Biomedica Engineered T Cells Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Autolus Limited
-
14.3.1 Autolus Limited Company Profile
-
14.3.2 Autolus Limited Engineered T Cells Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Cells Medica
-
14.4.1 Cells Medica Company Profile
-
14.4.2 Cells Medica Engineered T Cells Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Pfizer
-
14.5.1 Pfizer Company Profile
-
14.5.2 Pfizer Engineered T Cells Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Bellicum Pharmaceuticals
-
14.6.1 Bellicum Pharmaceuticals Company Profile
-
14.6.2 Bellicum Pharmaceuticals Engineered T Cells Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Precision Bioscience
-
14.7.1 Precision Bioscience Company Profile
-
14.7.2 Precision Bioscience Engineered T Cells Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Unum Therapeutics
-
14.8.1 Unum Therapeutics Company Profile
-
14.8.2 Unum Therapeutics Engineered T Cells Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Novartis
-
14.9.1 Novartis Company Profile
-
14.9.2 Novartis Engineered T Cells Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Juno Therapeutics
-
14.10.1 Juno Therapeutics Company Profile
-
14.10.2 Juno Therapeutics Engineered T Cells Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Gilead Sciences
-
14.11.1 Gilead Sciences Company Profile
-
14.11.2 Gilead Sciences Engineered T Cells Market Performance
-
14.11.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Engineered T Cells Industry Research Conclusions
-
15.2 Engineered T Cells Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Engineered T Cells Industry Market Size (2018-2029)
-
Figure China Engineered T Cells Production Volume, Production Value and Growth Rate of Chimeric Antigen Receptor (CAR) (2018-2029)
-
Figure China Engineered T Cells Production Volume, Production Value and Growth Rate of T Cell Receptor {TCR} (2018-2029)
-
Figure China Engineered T Cells Production Volume, Production Value and Growth Rate of Tumor Infiltrating Lymphocytes (2018-2029)
-
Figure China Engineered T Cells Sales Volume, Sales Value and Growth Rate of Cancer Research Centers (2018-2029)
-
Figure China Engineered T Cells Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)
-
Figure China Engineered T Cells Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure North China Engineered T Cells Market Size and Growth Rate from 2018-2029
-
Figure Central China Engineered T Cells Market Size and Growth Rate from 2018-2029
-
Figure South China Engineered T Cells Market Size and Growth Rate from 2018-2029
-
Figure East China Engineered T Cells Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Engineered T Cells Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Engineered T Cells Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Engineered T Cells Market Size and Growth Rate from 2018-2029
-
Figure Engineered T Cells Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Engineered T Cells Market Share by Type in 2018
-
Figure China Engineered T Cells Market Share by Type in 2023
-
Figure China Engineered T Cells Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Engineered T Cells Production Volume and Growth Rate of Chimeric Antigen Receptor (CAR) (2018-2023)
-
Figure China Engineered T Cells Production Volume and Growth Rate of T Cell Receptor {TCR} (2018-2023)
-
Figure China Engineered T Cells Production Volume and Growth Rate of Tumor Infiltrating Lymphocytes (2018-2023)
-
Figure China Engineered T Cells Market Share by Application in 2018
-
Figure China Engineered T Cells Market Share by Application in 2023
-
Figure China Engineered T Cells Total Market Size and Growth Rate from Consumption End
-
Figure China Engineered T Cells Market Size and Growth Rate of Cancer Research Centers (2018-2023)
-
Figure China Engineered T Cells Market Size and Growth Rate of Clinics (2018-2023)
-
Figure China Engineered T Cells Market Size and Growth Rate of Hospitals (2018-2023)
-
Table China Engineered T Cells Production Volume by Region (2018-2023)
-
Table China Engineered T Cells Production Volume Share by Region (2018-2023)
-
Figure China Engineered T Cells Production Volume Share by Region (2018-2023)
-
Table China Engineered T Cells Production Value by Region (2018-2023)
-
Table China Engineered T Cells Production Value Share by Region (2018-2023)
-
Figure China Engineered T Cells Production Value Share by Region (2018-2023)
-
Table China Engineered T Cells Sales Volume by Region (2018-2023)
-
Table China Engineered T Cells Sales Volume Share by Region (2018-2023)
-
Figure China Engineered T Cells Sales Volume Share by Region (2018-2023)
-
Table China Engineered T Cells Sales Value by Region (2018-2023)
-
Table China Engineered T Cells Sales Value Share by Region (2018-2023)
-
Figure China Engineered T Cells Sales Value Share by Region (2018-2023)
-
Table North China Engineered T Cells Production Volume by Type (2018-2023)
-
Table North China Engineered T Cells Production Volume Share by Type (2018-2023)
-
Figure North China Engineered T Cells Production Volume Share by Type (2018-2023)
-
Table North China Engineered T Cells Sales Volume by Application (2018-2023)
-
Table North China Engineered T Cells Sales Volume Share by Application (2018-2023)
-
Figure North China Engineered T Cells Sales Volume Share by Application (2018-2023)
-
Table Central China Engineered T Cells Production Volume by Type (2018-2023)
-
Table Central China Engineered T Cells Production Volume Share by Type (2018-2023)
-
Figure Central China Engineered T Cells Production Volume Share by Type (2018-2023)
-
Table Central China Engineered T Cells Sales Volume by Application (2018-2023)
-
Table Central China Engineered T Cells Sales Volume Share by Application (2018-2023)
-
Figure Central China Engineered T Cells Sales Volume Share by Application (2018-2023)
-
Table South China Engineered T Cells Production Volume by Type (2018-2023)
-
Table South China Engineered T Cells Production Volume Share by Type (2018-2023)
-
Figure South China Engineered T Cells Production Volume Share by Type (2018-2023)
-
Table South China Engineered T Cells Sales Volume by Application (2018-2023)
-
Table South China Engineered T Cells Sales Volume Share by Application (2018-2023)
-
Figure South China Engineered T Cells Sales Volume Share by Application (2018-2023)
-
Table East China Engineered T Cells Production Volume by Type (2018-2023)
-
Table East China Engineered T Cells Production Volume Share by Type (2018-2023)
-
Figure East China Engineered T Cells Production Volume Share by Type (2018-2023)
-
Table East China Engineered T Cells Sales Volume by Application (2018-2023)
-
Table East China Engineered T Cells Sales Volume Share by Application (2018-2023)
-
Figure East China Engineered T Cells Sales Volume Share by Application (2018-2023)
-
Table Northeast China Engineered T Cells Production Volume by Type (2018-2023)
-
Table Northeast China Engineered T Cells Production Volume Share by Type (2018-2023)
-
Figure Northeast China Engineered T Cells Production Volume Share by Type (2018-2023)
-
Table Northeast China Engineered T Cells Sales Volume by Application (2018-2023)
-
Table Northeast China Engineered T Cells Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Engineered T Cells Sales Volume Share by Application (2018-2023)
-
Table Southwest China Engineered T Cells Production Volume by Type (2018-2023)
-
Table Southwest China Engineered T Cells Production Volume Share by Type (2018-2023)
-
Figure Southwest China Engineered T Cells Production Volume Share by Type (2018-2023)
-
Table Southwest China Engineered T Cells Sales Volume by Application (2018-2023)
-
Table Southwest China Engineered T Cells Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Engineered T Cells Sales Volume Share by Application (2018-2023)
-
Table Northwest China Engineered T Cells Production Volume by Type (2018-2023)
-
Table Northwest China Engineered T Cells Production Volume Share by Type (2018-2023)
-
Figure Northwest China Engineered T Cells Production Volume Share by Type (2018-2023)
-
Table Northwest China Engineered T Cells Sales Volume by Application (2018-2023)
-
Table Northwest China Engineered T Cells Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Engineered T Cells Sales Volume Share by Application (2018-2023)
-
Table Redmile Group Company Profile
-
Table Redmile Group Engineered T Cells Revenue, Price and Gross (2018-2023)
-
Table Oxford Biomedica Company Profile
-
Table Oxford Biomedica Engineered T Cells Revenue, Price and Gross (2018-2023)
-
Table Autolus Limited Company Profile
-
Table Autolus Limited Engineered T Cells Revenue, Price and Gross (2018-2023)
-
Table Cells Medica Company Profile
-
Table Cells Medica Engineered T Cells Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Engineered T Cells Revenue, Price and Gross (2018-2023)
-
Table Bellicum Pharmaceuticals Company Profile
-
Table Bellicum Pharmaceuticals Engineered T Cells Revenue, Price and Gross (2018-2023)
-
Table Precision Bioscience Company Profile
-
Table Precision Bioscience Engineered T Cells Revenue, Price and Gross (2018-2023)
-
Table Unum Therapeutics Company Profile
-
Table Unum Therapeutics Engineered T Cells Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Engineered T Cells Revenue, Price and Gross (2018-2023)
-
Table Juno Therapeutics Company Profile
-
Table Juno Therapeutics Engineered T Cells Revenue, Price and Gross (2018-2023)
-
Table Gilead Sciences Company Profile
-
Table Gilead Sciences Engineered T Cells Revenue, Price and Gross (2018-2023)
-
